Clinical management of severe active ulcerative colitis in the TNF-a inhibitors era
Submitted: 26 November 2013
Accepted: 26 November 2013
Published: 17 December 2013
Accepted: 26 November 2013
Abstract Views: 1331
PDF: 838
HTML: 898
HTML: 898
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Similar Articles
- Mario Visconti, Autoimmune liver diseases: internist's guide from bench to bedside , Italian Journal of Medicine: Vol. 9 No. 1 (2015)
You may also start an advanced similarity search for this article.